Metropolitan Life Insurance Company (MetLife)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,586
| Closed | -$23.8K | – | 2011 |
|
|
2024
Q1 | $23.8K | Hold |
1,586
| – | – | ﹤0.01% | 1774 |
|
|
2023
Q4 | $23.8K | Buy |
1,586
+508
| +47% | +$7.62K | ﹤0.01% | 1837 |
|
|
2023
Q3 | $15.1K | Hold |
1,078
| – | – | ﹤0.01% | 2026 |
|
|
2023
Q2 | $11.2K | Buy |
+1,078
| New | +$11.2K | ﹤0.01% | 2241 |
|
|
2021
Q4 | – | Sell |
-5,563
| Closed | -$93.6K | – | 2830 |
|
|
2021
Q3 | $93.6K | Buy |
+5,563
| New | +$93.6K | ﹤0.01% | 2561 |
|
|
2021
Q2 | – | Sell |
-6,091
| Closed | -$119K | – | 2886 |
|
|
2021
Q1 | $119K | Hold |
6,091
| – | – | ﹤0.01% | 2346 |
|
|
2020
Q4 | $110K | Hold |
6,091
| – | – | ﹤0.01% | 2311 |
|
|
2020
Q3 | $117K | Hold |
6,091
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q2 | $159K | Sell |
6,091
-726
| -11% | -$19K | ﹤0.01% | 1959 |
|
|
2020
Q1 | $122K | Hold |
6,817
| – | – | ﹤0.01% | 1907 |
|
|
2019
Q4 | $227K | Sell |
6,817
-410
| -6% | -$13.7K | ﹤0.01% | 1828 |
|
|
2019
Q3 | $172K | Buy |
+7,227
| New | +$172K | ﹤0.01% | 1983 |
|